The IP-Cure-B General Assembly occurred on March 28-29, 2023.All the Principal Investigators and scientists involved in the project gathered in Milan to discuss the progress made in the framework of the project. ELPA representatives presented data and results in the framework of communication and dissemination being involved in the WP dedicated to these activities. The meeting was a great opportunity to exchange views and push the development of novel curative concepts for chronic hepatitis B (CHB).